Status:
UNKNOWN
Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
Severe Pneumonia
Immunosuppressed Hosts
Eligibility:
All Genders
18-75 years
Brief Summary
Serious pneumonia is a serious inflammation of the lungs caused by various pathogens, resulting in severe bacteraemia or toxemia, which in turn causes blood pressure drop, shock, blurred consciousness...
Eligibility Criteria
Inclusion
- ① Age ≥ 18 years, ≤ 75 years, male or female
- Patients diagnosed with severe pneumonia ③ Immunosuppressed patients
- Patient informed consent
Exclusion
- ① Pregnant women, lactating women and women who are at risk of pregnancy.
- Patients with malignant neoplasms that have metastasized extensively and are expected to have a short survival period.
- Patients with obstructive pneumonia and interstitial fibrosis due to lung tumours.
- refusal of the patient or the patient's family to participate in the study.
- Refusal of invasive mechanical ventilation and tracheal intubation by the patient or the patient's family.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04395066
Start Date
June 1 2020
End Date
June 1 2023
Last Update
May 20 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.